CellSource Future Growth
Future criteria checks 3/6
CellSource is forecast to grow earnings and revenue by 19.7% and 12.5% per annum respectively. EPS is expected to grow by 7.7% per annum. Return on equity is forecast to be 11.6% in 3 years.
Key information
19.7%
Earnings growth rate
7.7%
EPS growth rate
Life Sciences earnings growth | 22.7% |
Revenue growth rate | 12.5% |
Future return on equity | 11.6% |
Analyst coverage | Low |
Last updated | 30 Jun 2024 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
10/31/2026 | 5,829 | 902 | 833 | 961 | 3 |
10/31/2025 | 5,133 | 676 | 609 | 768 | 3 |
10/31/2024 | 4,646 | 562 | 257 | 575 | 3 |
4/30/2024 | 4,567 | 812 | 266 | 914 | N/A |
1/31/2024 | 4,624 | 850 | N/A | N/A | N/A |
10/31/2023 | 4,510 | 923 | 487 | 846 | N/A |
7/31/2023 | 4,807 | 1,103 | N/A | N/A | N/A |
4/30/2023 | 4,746 | 1,119 | 1,198 | 1,248 | N/A |
1/31/2023 | 4,512 | 1,078 | N/A | N/A | N/A |
10/31/2022 | 4,273 | 1,017 | 748 | 847 | N/A |
7/31/2022 | 3,690 | 812 | N/A | N/A | N/A |
4/30/2022 | 3,276 | 691 | 542 | 641 | N/A |
1/31/2022 | 3,120 | 693 | N/A | N/A | N/A |
10/31/2021 | 2,922 | 651 | 837 | 898 | N/A |
7/31/2021 | 2,648 | 544 | N/A | N/A | N/A |
4/30/2021 | 2,312 | 424 | 474 | 518 | N/A |
1/31/2021 | 2,033 | 310 | N/A | N/A | N/A |
10/31/2020 | 1,855 | 274 | 298 | 330 | N/A |
7/31/2020 | 1,750 | 212 | N/A | N/A | N/A |
10/31/2019 | 1,611 | 199 | 142 | 195 | N/A |
10/31/2018 | 1,212 | 193 | N/A | N/A | N/A |
10/31/2017 | 519 | 111 | N/A | N/A | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 4880's forecast earnings growth (19.7% per year) is above the savings rate (0.3%).
Earnings vs Market: 4880's earnings (19.7% per year) are forecast to grow faster than the JP market (8.6% per year).
High Growth Earnings: 4880's earnings are forecast to grow, but not significantly.
Revenue vs Market: 4880's revenue (12.5% per year) is forecast to grow faster than the JP market (4.3% per year).
High Growth Revenue: 4880's revenue (12.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 4880's Return on Equity is forecast to be low in 3 years time (11.6%).